IRB Approval Letter

EXEMPT DETERMINATION
January 19, 2023
Matthew Farrelly
919-541-6852
[email protected]
Dear Matthew Farrelly:
On 1/19/2023, the IRB reviewed the following submission:
Type of Review: Initial Study
Title: Increasing Understanding of Digital Advertising:
Awareness, Receptivity & Comprehension
Experiment
Investigator: Matthew Farrelly
IRB ID: STUDY00022310
Funding Source: FDA Ctr Tobacco Products
Customer/Client Name: FDA Ctr Tobacco Products
Project/Proposal Number: 0215534.009
Contract/Grant Number: HHSF223201610032I
IND, IDE, or HDE: None
The IRB determined that this study meets the criteria for exemption from IRB review
under Category (2) (iii) Tests, surveys, interviews, or observation (identifiable); and for
which limited IRB review was conducted via expedited review.
Ongoing IRB review and approval by this organization is not required. This
determination applies only to the activities described in the IRB submission and may not
apply should any changes be made. If changes are made and there are questions about
whether these activities impact the exempt determination, you should contact the IRB to
discuss whether a new submission and determination is necessary.
Sincerely,
The RTI Office of Research Protection

Page 1 of 1